| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 103 |
| 1 | ACETAMINOPHEN | 87 |
| 2 | DIPHENHYDRAMINE HYDROCHLORIDE | 63 |
| 3 | ACETAMINOPHEN 500MG | 59 |
| 4 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 59 |
| 5 | INFLIXIMAB | 59 |
| 6 | PAIN RELIEVER | 59 |
| 7 | METHOTREXATE SODIUM | 58 |
| 8 | METHOTREXATE | 55 |
| 9 | INFLIXIMAB-DYYB | 51 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | 1 | 0.0769 |
| 1 | COAGULATION FACTOR X HUMAN | 1 | 0.0286 |
| 2 | INFLIXIMAB-DYYB | 51 | 0.0148 |
| 3 | C1 ESTERASE INHIBITOR RECOMBINANT | 44 | 0.0068 |
| 4 | AXATILIMAB-CSFR | 1 | 0.0061 |
| 5 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 6 | LANADELUMAB-FLYO | 13 | 0.0040 |
| 7 | ACETIC ACID | 1 | 0.0028 |
| 8 | RIVASTIGMINE TARTRATE | 1 | 0.0022 |
| 9 | DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE | 1 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 153 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 119 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 76 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 55 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 52 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 44 |
| 6 | Vitamin C [EPC] | 44 |
| 7 | Expectorant [EPC] | 43 |
| 8 | Benzodiazepine [EPC] | 42 |
| 9 | Vitamin B12 [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 6 | 0.0010 |
| 2 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 20 | 0.0006 |
| 4 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 5 | Photoenhancer [EPC] | 2 | 0.0005 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 7 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 6 | 0.0004 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 28 | 0.0003 |